BioSpace News Archive

CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the COVID-19 Transplant Registry (C19TxR.org).

HEMA Biologics, LLC, (“HEMA Biologics”) today announced that the U.S. Food and Drug Administration (FDA) approved SEVENFACT® [coagulation factor VIIa (recombinant)-jncw] as the first new bypassing agent in over 20 years for adults and adolescents (12 years of age and older) with hemophilia A and B with inhibitors.

Annual Meeting to be webcast in virtual-only format

Medable Inc., the leading global platform for decentralized clinical trials, and MRN today announced a global alliance to bring shared capabilities to decentralized clinical trials.

Boston Biomedical, Inc. today announced the first patient has been dosed in a phase 1 study evaluating the investigational agent TP-3654, a PIM kinase inhibitor, in patients with intermediate-2 and high-risk primary or secondary myelofibrosis.

Drugs for the treatment of COVID-19 are in desperate need world-wide. A rapid drug discovery platform that can help identify drugs for the treatment of COVID-19 is essential for identifying viable treatments.

Percy Van Crocker, Jr., MBA, an entrepreneur who has spent his 20+ year career driving innovation and change in healthcare and technology, recently joined Cancer Treatment Centers of America’s® (CTCA) Oncology Data, Analytics & Research Business as President and Co-Founder.

Tampa General Hospital is offering two convenient ways for community members to be screened and tested for COVID-19.

Hillrom will host its fiscal second quarter 2020 earnings conference call and webcast on Friday, May 1, 2020, beginning at 7:30 a.m. / 8:30 a.m.

Provides Preliminary Revenue Range for the First Quarter 2020 and Withdraws Prior Annual Revenue Guidance for 2020 Due to COVID-19 Impact